Aarhus University Seal

Dansk

You are here: » Organisational barriers to thrombolysis treatment of acut...

About Aarhus University

Organisational barriers to thrombolysis treatment of acute ischaemic stroke

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

Standard

Organisational barriers to thrombolysis treatment of acute ischaemic stroke. / Ehlers, Lars; Jensen, Lotte Groth; Bech, Merete A et al.
In: Current Medical Research and Opinion, Vol. 23, No. 11, 11.2007, p. 2833-9.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

Harvard

Ehlers, L, Jensen, LG, Bech, MA, Andersen, G & Kjølby, M 2007, 'Organisational barriers to thrombolysis treatment of acute ischaemic stroke', Current Medical Research and Opinion, vol. 23, no. 11, pp. 2833-9. https://doi.org/10.1185/030079907X242557

APA

Ehlers, L., Jensen, L. G., Bech, M. A., Andersen, G., & Kjølby, M. (2007). Organisational barriers to thrombolysis treatment of acute ischaemic stroke. Current Medical Research and Opinion, 23(11), 2833-9. https://doi.org/10.1185/030079907X242557

CBE

Ehlers L, Jensen LG, Bech MA, Andersen G, Kjølby M. 2007. Organisational barriers to thrombolysis treatment of acute ischaemic stroke. Current Medical Research and Opinion. 23(11):2833-9. https://doi.org/10.1185/030079907X242557

MLA

Ehlers, Lars et al. "Organisational barriers to thrombolysis treatment of acute ischaemic stroke". Current Medical Research and Opinion. 2007, 23(11). 2833-9. https://doi.org/10.1185/030079907X242557

Vancouver

Ehlers L, Jensen LG, Bech MA, Andersen G, Kjølby M. Organisational barriers to thrombolysis treatment of acute ischaemic stroke. Current Medical Research and Opinion. 2007 Nov;23(11):2833-9. doi: 10.1185/030079907X242557

Author

Ehlers, Lars ; Jensen, Lotte Groth ; Bech, Merete A et al. / Organisational barriers to thrombolysis treatment of acute ischaemic stroke. In: Current Medical Research and Opinion. 2007 ; Vol. 23, No. 11. pp. 2833-9.

Bibtex

@article{9148b0d45bca42018c5ddb36714bbb33,
title = "Organisational barriers to thrombolysis treatment of acute ischaemic stroke",
abstract = "BACKGROUND: Intravenous thrombolysis with fibrinolytic drugs such as alteplase is not implemented widely in any country although the treatment is both effective and cost-effective in selected patients within a 3-h window after acute ischaemic stroke. The purpose of the present study was to describe the organisational barriers to delivery of thrombolysis for acute ischaemic stroke with special regard to the Danish healthcare system.METHOD: Systematic and unsystematic searches of medical, economic and grey literature on organisational barriers to thrombolysis treatment were performed in Cochrane, PubMed, EMBASE, Cinahl, Econlit, NHS EED, SvedMed+ and the Health Technology Assessment (HTA) database. The search periods were 1996-2006.FINDINGS: Three main types of literature on organisational barriers were found: medical literature including HTA reports on barriers related to the 3-h window, economic literature on barriers related to the lack of capacity to provide the treatment on a 24-h basis, and grey literature/policy papers on standards and demands to the hospitals and healthcare systems who implements the treatment.CONCLUSION: Information on organisational barriers can be extracted from different types of literature (medical, economic and grey literature/policy papers), but organisational barriers are most often not the primary study objective in the relevant literature. This review showed a broad spectrum of possible organisational barriers to the delivery of thrombolysis treatment of acute ischaemic stroke.",
keywords = "Brain Ischemia, Denmark, Fibrinolytic Agents, Humans, Stroke",
author = "Lars Ehlers and Jensen, {Lotte Groth} and Bech, {Merete A} and Grethe Andersen and Mette Kj{\o}lby",
year = "2007",
month = nov,
doi = "10.1185/030079907X242557",
language = "English",
volume = "23",
pages = "2833--9",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Taylor & Francis ",
number = "11",

}

RIS

TY - JOUR

T1 - Organisational barriers to thrombolysis treatment of acute ischaemic stroke

AU - Ehlers, Lars

AU - Jensen, Lotte Groth

AU - Bech, Merete A

AU - Andersen, Grethe

AU - Kjølby, Mette

PY - 2007/11

Y1 - 2007/11

N2 - BACKGROUND: Intravenous thrombolysis with fibrinolytic drugs such as alteplase is not implemented widely in any country although the treatment is both effective and cost-effective in selected patients within a 3-h window after acute ischaemic stroke. The purpose of the present study was to describe the organisational barriers to delivery of thrombolysis for acute ischaemic stroke with special regard to the Danish healthcare system.METHOD: Systematic and unsystematic searches of medical, economic and grey literature on organisational barriers to thrombolysis treatment were performed in Cochrane, PubMed, EMBASE, Cinahl, Econlit, NHS EED, SvedMed+ and the Health Technology Assessment (HTA) database. The search periods were 1996-2006.FINDINGS: Three main types of literature on organisational barriers were found: medical literature including HTA reports on barriers related to the 3-h window, economic literature on barriers related to the lack of capacity to provide the treatment on a 24-h basis, and grey literature/policy papers on standards and demands to the hospitals and healthcare systems who implements the treatment.CONCLUSION: Information on organisational barriers can be extracted from different types of literature (medical, economic and grey literature/policy papers), but organisational barriers are most often not the primary study objective in the relevant literature. This review showed a broad spectrum of possible organisational barriers to the delivery of thrombolysis treatment of acute ischaemic stroke.

AB - BACKGROUND: Intravenous thrombolysis with fibrinolytic drugs such as alteplase is not implemented widely in any country although the treatment is both effective and cost-effective in selected patients within a 3-h window after acute ischaemic stroke. The purpose of the present study was to describe the organisational barriers to delivery of thrombolysis for acute ischaemic stroke with special regard to the Danish healthcare system.METHOD: Systematic and unsystematic searches of medical, economic and grey literature on organisational barriers to thrombolysis treatment were performed in Cochrane, PubMed, EMBASE, Cinahl, Econlit, NHS EED, SvedMed+ and the Health Technology Assessment (HTA) database. The search periods were 1996-2006.FINDINGS: Three main types of literature on organisational barriers were found: medical literature including HTA reports on barriers related to the 3-h window, economic literature on barriers related to the lack of capacity to provide the treatment on a 24-h basis, and grey literature/policy papers on standards and demands to the hospitals and healthcare systems who implements the treatment.CONCLUSION: Information on organisational barriers can be extracted from different types of literature (medical, economic and grey literature/policy papers), but organisational barriers are most often not the primary study objective in the relevant literature. This review showed a broad spectrum of possible organisational barriers to the delivery of thrombolysis treatment of acute ischaemic stroke.

KW - Brain Ischemia

KW - Denmark

KW - Fibrinolytic Agents

KW - Humans

KW - Stroke

U2 - 10.1185/030079907X242557

DO - 10.1185/030079907X242557

M3 - Journal article

C2 - 17910781

VL - 23

SP - 2833

EP - 2839

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 11

ER -